Symbol: |
MTA1
|
Description: |
metastasis associated 1 [Source:HGNC Symbol;Acc:7410]
|
Location: |
Chr14:105886159-105937066[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:231
Gene |
Compound |
Gen_sig |
Exp_pattern |
MTA1 |
NSC 23416 |
0.008 |
Down |
MTA1 |
Butanedioic acid, 2-bromo-3-fluoro-, dimethyl ester |
0.04 |
Down |
MTA1 |
NSC 26112 |
0.024 |
Down |
MTA1 |
6-Benzylthioinosine |
0.032 |
Down |
MTA1 |
NSC 270927 |
0.007 |
Down |
MTA1 |
1,7-Heptanediamine, N,N'-bis(2-methyl-7-nitro-4-quinolinyl)-, dihydrochloride |
0.02 |
Down |
MTA1 |
Mitoxantrone |
0.044 |
Down |
MTA1 |
NSC 294526 |
0.007 |
Down |
MTA1 |
CYCLOMETHYLENOMYCIN A |
0.03 |
Down |
MTA1 |
Hydrazinecarbodithioic acid, [1-(2-pyridinyl)ethylidene]-, phenylmethyl ester |
0.013 |
Down |
MTA1 |
NSC 295642 |
0.001 |
Down |
MTA1 |
Avarol |
0.047 |
Down |
MTA1 |
AI 3-63984 |
0.001 |
Down |
MTA1 |
1-Piperazinecarboselenoic acid, 4-(2-pyridinyl)-, [1-(2-pyridinyl)ethylidene]hydrazide |
0.022 |
Down |
MTA1 |
ANTINEOPLASTIC-328785 |
0.001 |
Down |
Expression pattern: Sensitivity / Resistance
Total:16 Current:3
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:36
Total:3 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:52
Total:4 Current:1
[First] [Prev]  Next Last 
|